Why Investors Are Betting Billions on Full-Body Scanning as Healthcare's Future
Spotify founder Daniel Ek's Neko Health secured $700 million for preventative body scanning, but it's far from alone in this emerging category. We spoke with a key backer about why the industry sees such potential.

https://playlist.megaphone.fm?e=TCML7767615384%20
A wave of venture capital is flowing into companies that use advanced scanning technology to detect health issues before symptoms emerge. Neko Health, backed by Spotify's Daniel Ek, just raised $700 million on this thesis, yet competitors like Midjourney and Function Health are also building similar platforms and securing substantial funding. The question driving investor interest: can body scanning become a standard part of how Americans manage their health?
On the latest episode of TechCrunch's Equity podcast, host Dominic-Madori Davis spoke with Farooq Abbasi, founder and general partner of Preface Ventures and an investor in Neko Health, to explore how the company stacks up against other consumer-health ventures and what needs to happen for scanning to integrate into the mainstream healthcare system.
The conversation covers several key topics:
- Abbasi's decision to invest in Neko after experiencing the company's scan firsthand
- The specifics of Neko's $500 scan offering and the operational strategies that enable its pricing
- Abbasi's perspective on inadequate primary-care usage as a critical gap in U.S. healthcare delivery
- His assessment that certain consumer-health startups may be receiving excessive funding
- The potential for richer health datasets to fuel the next generation of AI-driven medical applications
Equity is available on YouTube, Apple Podcasts, Overcast, Spotify and other podcast platforms. Follow the show on X and Threads at @EquityPod.


